(Press-News.org) Long-term use of highly active antiretroviral therapies (HAART) does not appear to be associated with impaired heart function in children and adolescents in a study that sought to determine the cardiac effects of prolonged exposure to HAART on children infected with the human immunodeficiency virus (HIV), according to a report published Online First by JAMA Pediatrics, a JAMA Network publication.
Prior to contemporary antiretroviral therapies (ARTs), children infected with HIV were more likely to have heart failure.
Steven E. Lipshultz, M.D., of the University of Miami Leonard M. Miller School of Medicine, Florida, and colleagues used statistical models to compare echocardiographic measures in the National Institutes of Health-funded Pediatric HIV/AIDS Cohort Study's Adolescent Master Protocol (AMP).
The study included 14 pediatric HIV clinics in the United States. The participants were 325 perinatally HIV-infected children receiving HAART; 189 HIV-exposed but uninfected children; and 70 HIV-infected (mostly HAART-unexposed) historical pediatric controls patients from the National Institutes of Health-funded Pulmonary and Cardiovascular Complications of Vertically Transmitted HIV Infection (P2C2-HIV) Study.
"Our results indicate that the current use of combination ART, usually HAART, appears to be cardioprotective in HIV-infected children and adolescents. This finding is even more relevant in the developing world where the prevalence of HIV disease in children is much higher," the study notes.
Scores for left ventricular (LV) fractional shortening (a measure of cardiac function) were significantly lower among HIV-infected children from the P2C2-HIV Study than among the AMP HIV-infected group or the 189 AMP HIV-exposed but uninfected controls, the study results indicate. The results also show that for HIV-infected children, a lower nadir CD4 percentage and a higher current viral load were associated with significantly lower cardiac function.
"This study suggests that highly active ART (HAART) does not appear to impair heart function," the study concludes.
###
(JAMA Pediatr. Published online April 22, 2013. doi:10.1001/jamapediatrics.2013.1206. Available pre-embargo to the media at http://media.jamanetwork.com.)
Editor's Note: The authors disclosed numerous funding and support sources including the Eunice Kennedy Shriver National Institute of Child Health and Human Development, the National Institute on Drug Abuse, the National Institute of Allergy and Infectious Diseases and the Office of AIDS Research. Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.
Highly active antiretroviral therapies may be cardioprotective in HIV-infected children, teens
2013-04-23
ELSE PRESS RELEASES FROM THIS DATE:
Study evaluates Mobile Acute Care of the Elderly (MACE) service vs. usual elder care
2013-04-23
A matched cohort study by William W. Hung, M.D., M.P.H., of the Mount Sinai School of Medicine, New York, and colleagues examined the use of the Mobile Acute Care of the Elderly (MACE) service compared with general medical service (usual care). (Online First)
Patients were recruited for the study if they were 75 years or older and were admitted because of an acute illness to either the MACE service, a novel model of care delivered by an interdisciplinary team and designed to deliver specialized care to hospitalized older adults to improve patient outcomes, or usual care. ...
Diagnostic errors more common, costly and harmful than treatment mistakes
2013-04-23
In reviewing 25 years of U.S. malpractice claim payouts, Johns Hopkins researchers found that diagnostic errors — not surgical mistakes or medication overdoses — accounted for the largest fraction of claims, the most severe patient harm, and the highest total of penalty payouts. Diagnosis-related payments amounted to $38.8 billion between 1986 and 2010, they found.
"This is more evidence that diagnostic errors could easily be the biggest patient safety and medical malpractice problem in the United States," says David E. Newman-Toker, M.D., Ph.D., an associate professor ...
'Clean' your memory to pick a winner
2013-04-23
Predicting the winner of a sporting event with accuracy close to that of a statistical computer programme could be possible with proper training, according to researchers.
In a study published today, experiment participants who had been trained on statistically idealised data vastly improved their ability to predict the outcome of a baseball game.
In normal situations, the brain selects a limited number of memories to use as evidence to guide decisions. As real-world events do not always have the most likely outcome, retrieved memories can provide misleading information ...
Alternative therapies may help lower blood pressure
2013-04-23
Alternative therapies such as aerobic exercise, resistance or strength training, and isometric hand grip exercises may help reduce your blood pressure, according to the American Heart Association.
In a new scientific statement published in its journal Hypertension, the association said alternative approaches could help people with blood pressure levels higher than 120/80 mm Hg and those who can't tolerate or don't respond well to standard medications.
However, alternative therapies shouldn't replace proven methods to lower blood pressure — including physical activity, ...
Retrospective study suggests that patients with lung cancer who carry specific HER2 mutations may benefit from certain anti-HER2 treatments
2013-04-23
New results from a retrospective study conducted in Europe suggest that anti-HER2 treatments, like the widely used breast cancer agent trastuzumab (Herceptin), have anti-cancer effects in a small subset of patients with advanced non-small cell lung cancer (NSCLC) harboring specific HER2 protein mutations. Although genetic changes cause tumor cells to make too much of the HER2 protein in up to 20% of lung cancers, mutations in the HER2 gene occur in only 1-2% of lung cancers. Such mutations in the HER2 gene lead to continuous activation of the protein, which keeps tumor ...
3 unique genes found to influence body size and obesity in people of African ancestry
2013-04-23
Researchers from Dartmouth's Institute for Quantitative Biomedical Sciences (iQBS) and the Center for Genomic Medicine have helped to discover three unique genetic variations that influence body size and obesity in men and women of African ancestry. This study, a meta-analysis that examined 3.2 million genetic variants in over 30,000 people with African heritage for links to body-mass index or BMI—by professors Jason Moore, Christopher Amos and Scott Williams—was the largest ever done on this population to date. The study was published online in April 2013 by Nature Genetics, ...
Discovery of new genes will help childhood arthritis treatment
2013-04-23
Scientists from The University of Manchester have identified 14 new genes which could have important consequences for future treatments of childhood arthritis. Scientists Dr Anne Hinks, Dr Joanna Cobb and Professor Wendy Thomson, from the University's Arthritis Research UK Epidemiology Unit, whose work is published in Nature Genetics yesterday (21 April), looked at DNA extracted from blood and saliva samples of 2,000 children with childhood arthritis and compared these to healthy people.
Principal Investigator Professor Thomson, who also leads the Inflammatory Arthritis ...
Latest research shows 2 items are key to decrease symptoms and prolong survival for LMC patients
2013-04-23
DENVER – Lung cancer is one of the most common primary cancers that cause leptomeningeal carcinomatosis (LMC), when cancer spreads to the membranes surrounding the spinal cord and brain. Cases of LMC have increased because of the improved survival of lung cancer patients with the help of new advances in treatment. This is the type of cancer diagnosis facingValerie Harper, who played Rhonda on "The Mary Tyler Moore Show."
Now research published in the International Association for the Study of Lung Cancer's Journal of Thoracic Oncology (JTO) shows the effectiveness of ...
Tumors with ALK rearrangements can harbor more mutations
2013-04-23
DENVER – The identification of potentially targetable kinase mutations has been an exciting advancement in lung cancer treatment. Although the mutations driving many lung carcinomas remain unknown, approximately 50 percent of lung adenocarcinoma cases harbor KRAS mutation, EGFR mutation, or ALK translocation, and an additional 5 percent or so have been shown to have mutations involving BRAF, PIK3CA, HER2, MET, MEK1, NRAS, and AKT. In the vast majority, these driver mutations are mutually exclusive. But in a recent study published in the International Association for the ...
Lung cancer mortality rates linked to primary care provider density
2013-04-23
DENVER – Lung cancer remains the leading cause of cancer-related deaths and is tied as the third leading cause of death overall in industrialized countries. Within the United States, several groups identified by race, sex, and socioeconomic status have been linked to increased cancer mortality, suggesting a disparity because of these characteristics. The relationships are complicated by the fact that many of these characteristics may also be associated with areas of decreased access to care and local resources and not inherently based on implicit biases. Researchers from ...